Generated by GPT-5-mini| European Society for Immunodeficiencies | |
|---|---|
| Name | European Society for Immunodeficiencies |
| Abbreviation | ESID |
| Formation | 1983 |
| Type | Professional association |
| Headquarters | Utrecht, Netherlands |
| Region served | Europe |
| Membership | Clinicians, researchers, allied health professionals |
European Society for Immunodeficiencies is a professional association that brings together clinicians, researchers, and allied health professionals working on primary immunodeficiency disorders across Europe. It fosters collaboration among specialists associated with institutions such as University College London, Charité – Universitätsmedizin Berlin, and Institut Pasteur and engages with policy stakeholders like European Commission and patient organizations including Primary Immunodeficiency UK. The society organizes conferences comparable to meetings at European Congress of Clinical Microbiology & Infectious Diseases and liaises with global bodies such as the World Health Organization, American Academy of Allergy, Asthma & Immunology, and International Union of Immunological Societies.
Founded in 1983 by clinicians influenced by work at Great Ormond Street Hospital, Bambino Gesù Hospital, and research groups at Harvard Medical School, the society emerged during the same era that saw breakthroughs at Cold Spring Harbor Laboratory and Max Planck Institute for Infection Biology. Early figures drew on clinical series reported from Mayo Clinic and translational studies published through New England Journal of Medicine and The Lancet. As the field advanced with discoveries at National Institutes of Health and genetic insights from Wellcome Sanger Institute, the society expanded its remit to policy engagement with the Council of Europe and collaborative registries inspired by models at European Centre for Disease Prevention and Control.
The society's mission aligns with objectives promoted by European Medicines Agency, World Health Organization, and patient advocacy groups like European Patient Forum: to improve diagnosis, care, and research for primary immunodeficiencies. Objectives include building networks similar to European Research Council consortia, promoting standards akin to guidelines from National Institute for Health and Care Excellence, and supporting translational pipelines exemplified by partnerships with Horizon 2020 consortia and foundations such as Bill & Melinda Gates Foundation.
Governance structures mirror governance at organizations like European Respiratory Society and European Hematology Association, with an elected executive board, scientific advisory committees, and working groups coordinated from administrative hubs in cities like Utrecht and Geneva. The board collaborates with legal advisers versed in frameworks of the European Court of Justice and funding officers experienced with grants from European Commission directorates. Committees often include representatives who have affiliations with Imperial College London, University of Oxford, and national health institutes such as Robert Koch Institute.
The society organizes annual meetings analogous to gatherings at European Society of Cardiology and thematic symposia that echo formats used by European Academy of Allergy and Clinical Immunology. Programs include multicenter registries modeled on initiatives from European Society for Blood and Marrow Transplantation, public awareness campaigns in partnership with groups like Rare Diseases Europe, and policy briefings presented to delegations at European Parliament. It facilitates clinical networks comparable to networks supported by European Reference Networks and runs patient-focused sessions with collaborators such as Cystic Fibrosis Europe for cross-disease learning.
Educational offerings mirror curricula from European Board of Immunology programs and incorporate training modules similar to those at European Molecular Biology Laboratory and Cold Spring Harbor Laboratory courses. The society supports investigator-initiated studies drawing on genomic resources from European Genome-phenome Archive and translational trials undertaken at hubs like GOSH Research Institute and Karolinska Institutet. It runs summer schools and fellowships patterned after programs at Wellcome Trust and exchanges with institutions including Sanger Institute and Institut Curie.
Membership comprises clinicians, researchers, nurses, and allied professionals affiliated with university hospitals such as Addenbrooke's Hospital, research centers like Francis Crick Institute, and national societies including British Society for Immunology and German Society for Immunology. Chapters and working groups exist in regions represented by Nordic Immunology Societies, Mediterranean Clinical Networks, and national bodies such as Associazione Italiana per le Immunodeficienze Primitive. Membership benefits include access to collaborative registries, educational bursaries, and participation in guideline development with stakeholders like European Medicines Agency.
The society confers awards comparable to honors from European Research Council and publishes findings and guidelines in journals that overlap audiences with Journal of Clinical Immunology, The Lancet Haematology, and Clinical & Experimental Immunology. It issues consensus statements and diagnostic criteria cited alongside documents from International Union of Immunological Societies and disseminates newsletters and position papers used by practitioners at St Thomas' Hospital and researchers at University of Cambridge.
Category:Medical associations based in Europe Category:Immunology organizations